Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-19-002450
Filing Date
2019-02-14
Accepted
2019-02-14 10:18:05
Documents
1
Group Members
PONTIFAX (CAYMAN) IV, L.P.PONTIFAX (CHINA) IV, L.P.PONTIFAX (ISRAEL) 4, LIMITED PARTNERSHIPPONTIFAX 4 GP, LIMITED PARTNERSHIPPONTIFAX MANAGEMENT 4 GP (2015) LTD.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0219pontifax_entera.htm SC 13G 254872
  Complete submission text file 0001213900-19-002450.txt   256472
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G

Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Subject) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90847 | Film No.: 19602059
SIC: 2836 Biological Products, (No Diagnostic Substances)